Annual Revenue
$1.20 B
+$62.95 M+5.53%
31 December 2022
Summary:
NuVasive annual revenue is currently $1.20 billion, with the most recent change of +$62.95 million (+5.53%) on 31 December 2022. During the last 3 years, it has risen by +$62.95 million (+5.53%).NUVA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$317.79 M
+$10.07 M+3.27%
30 June 2023
Summary:
NuVasive quarterly revenue is currently $317.79 million, with the most recent change of +$10.07 million (+3.27%) on 30 June 2023.NUVA Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$1.23 B
+$7.33 M+0.60%
30 June 2023
Summary:
NuVasive TTM revenue is currently $1.23 billion, with the most recent change of +$7.33 million (+0.60%) on 30 June 2023.NUVA TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVA Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +5.5% | +5.2% | +7.7% |
| 5 y5 years | +2.9% | +2.4% | +5.0% |
NUVA Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | at high | at high |
NuVasive Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $317.79 M(+3.3%) | $1.23 B(+0.6%) |
| Mar 2023 | - | $307.71 M(+0.7%) | $1.22 B(+1.4%) |
| Dec 2022 | $1.20 B(+5.5%) | $305.45 M(+3.4%) | $1.20 B(+0.3%) |
| Sept 2022 | - | $295.28 M(-4.9%) | $1.20 B(+2.1%) |
| June 2022 | - | $310.45 M(+6.8%) | $1.17 B(+1.3%) |
| Mar 2022 | - | $290.76 M(-3.7%) | $1.16 B(+1.7%) |
| Dec 2021 | $1.14 B(+8.4%) | $302.07 M(+11.5%) | $1.14 B(+0.9%) |
| Sept 2021 | - | $270.84 M(-8.1%) | $1.13 B(-2.1%) |
| June 2021 | - | $294.83 M(+8.7%) | $1.15 B(+8.6%) |
| Mar 2021 | - | $271.25 M(-7.0%) | $1.06 B(+1.1%) |
| Dec 2020 | $1.05 B(-10.1%) | $291.81 M(-1.2%) | $1.05 B(-1.7%) |
| Sept 2020 | - | $295.28 M(+45.0%) | $1.07 B(+0.4%) |
| June 2020 | - | $203.61 M(-21.7%) | $1.06 B(-7.7%) |
| Mar 2020 | - | $259.88 M(-16.3%) | $1.15 B(-1.3%) |
| Dec 2019 | $1.17 B(+6.0%) | $310.35 M(+6.7%) | $1.17 B(+1.9%) |
| Sept 2019 | - | $290.83 M(-0.4%) | $1.15 B(+1.7%) |
| June 2019 | - | $292.11 M(+6.3%) | $1.13 B(+0.9%) |
| Mar 2019 | - | $274.78 M(-4.7%) | $1.12 B(+1.3%) |
| Dec 2018 | $1.10 B(+7.3%) | $288.33 M(+6.3%) | $1.10 B(+1.6%) |
| Sept 2018 | - | $271.30 M(-3.6%) | $1.08 B(+2.3%) |
| June 2018 | - | $281.56 M(+8.1%) | $1.06 B(+2.1%) |
| Mar 2018 | - | $260.52 M(-3.9%) | $1.04 B(+1.1%) |
| Dec 2017 | $1.03 B(+6.7%) | $271.22 M(+9.8%) | $1.03 B(+0.0%) |
| Sept 2017 | - | $247.05 M(-4.8%) | $1.03 B(+0.7%) |
| June 2017 | - | $259.40 M(+4.2%) | $1.02 B(+2.3%) |
| Mar 2017 | - | $249.01 M(-8.2%) | $996.04 M(+3.5%) |
| Dec 2016 | $962.13 M(+18.6%) | $271.17 M(+13.2%) | $962.13 M(+6.2%) |
| Sept 2016 | - | $239.65 M(+1.5%) | $906.25 M(+4.5%) |
| June 2016 | - | $236.21 M(+9.8%) | $867.13 M(+4.0%) |
| Mar 2016 | - | $215.10 M(-0.1%) | $833.83 M(+2.8%) |
| Dec 2015 | $811.11 M(+6.4%) | $215.28 M(+7.4%) | $811.11 M(+1.4%) |
| Sept 2015 | - | $200.54 M(-1.2%) | $800.16 M(+1.3%) |
| June 2015 | - | $202.91 M(+5.5%) | $789.54 M(+1.6%) |
| Mar 2015 | - | $192.38 M(-5.8%) | $777.30 M(+2.0%) |
| Dec 2014 | $762.41 M(+11.3%) | $204.32 M(+7.6%) | $762.42 M(+1.8%) |
| Sept 2014 | - | $189.92 M(-0.4%) | $748.91 M(+2.9%) |
| June 2014 | - | $190.68 M(+7.4%) | $728.14 M(+3.6%) |
| Mar 2014 | - | $177.50 M(-7.0%) | $703.16 M(+2.6%) |
| Dec 2013 | $685.17 M(+10.5%) | $190.81 M(+12.8%) | $685.17 M(+3.8%) |
| Sept 2013 | - | $169.16 M(+2.1%) | $660.11 M(+3.2%) |
| June 2013 | - | $165.70 M(+3.9%) | $639.35 M(+1.8%) |
| Mar 2013 | - | $159.50 M(-3.8%) | $628.07 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $620.25 M(+14.8%) | $165.75 M(+11.7%) | $620.25 M(+2.6%) |
| Sept 2012 | - | $148.39 M(-3.9%) | $604.70 M(+2.6%) |
| June 2012 | - | $154.42 M(+1.8%) | $589.18 M(+3.8%) |
| Mar 2012 | - | $151.69 M(+1.0%) | $567.73 M(+5.0%) |
| Dec 2011 | $540.51 M(+13.0%) | $150.19 M(+13.0%) | $540.51 M(+4.0%) |
| Sept 2011 | - | $132.88 M(-0.1%) | $519.62 M(+2.5%) |
| June 2011 | - | $132.97 M(+6.8%) | $507.00 M(+2.7%) |
| Mar 2011 | - | $124.47 M(-3.7%) | $493.62 M(+3.2%) |
| Dec 2010 | $478.24 M(+29.1%) | $129.30 M(+7.5%) | $478.24 M(+4.9%) |
| Sept 2010 | - | $120.26 M(+0.6%) | $455.87 M(+5.9%) |
| June 2010 | - | $119.58 M(+9.6%) | $430.52 M(+7.8%) |
| Mar 2010 | - | $109.09 M(+2.0%) | $399.42 M(+7.9%) |
| Dec 2009 | $370.34 M(+48.1%) | $106.94 M(+12.7%) | $370.34 M(+9.6%) |
| Sept 2009 | - | $94.92 M(+7.3%) | $337.99 M(+9.0%) |
| June 2009 | - | $88.48 M(+10.6%) | $309.99 M(+11.1%) |
| Mar 2009 | - | $80.01 M(+7.3%) | $278.92 M(+11.5%) |
| Dec 2008 | $250.08 M(+62.1%) | $74.58 M(+11.5%) | $250.10 M(+12.4%) |
| Sept 2008 | - | $66.92 M(+16.5%) | $222.45 M(+14.6%) |
| June 2008 | - | $57.42 M(+12.2%) | $194.05 M(+12.7%) |
| Mar 2008 | - | $51.18 M(+9.1%) | $172.25 M(+11.6%) |
| Dec 2007 | $154.29 M(+57.3%) | $46.93 M(+21.8%) | $154.29 M(+11.9%) |
| Sept 2007 | - | $38.52 M(+8.2%) | $137.85 M(+10.7%) |
| June 2007 | - | $35.62 M(+7.2%) | $124.52 M(+11.6%) |
| Mar 2007 | - | $33.22 M(+9.0%) | $111.63 M(+13.8%) |
| Dec 2006 | $98.09 M(+56.7%) | $30.49 M(+21.0%) | $98.09 M(+13.5%) |
| Sept 2006 | - | $25.19 M(+10.9%) | $86.42 M(+12.9%) |
| June 2006 | - | $22.72 M(+15.4%) | $76.54 M(+10.9%) |
| Mar 2006 | - | $19.68 M(+4.6%) | $69.02 M(+10.2%) |
| Dec 2005 | $62.61 M(+60.2%) | $18.82 M(+22.9%) | $62.61 M(+11.2%) |
| Sept 2005 | - | $15.31 M(+0.7%) | $56.30 M(+10.0%) |
| June 2005 | - | $15.20 M(+14.6%) | $51.17 M(+14.3%) |
| Mar 2005 | - | $13.27 M(+6.1%) | $44.77 M(+14.5%) |
| Dec 2004 | $39.09 M(+72.5%) | $12.51 M(+22.8%) | $39.09 M(+47.1%) |
| Sept 2004 | - | $10.18 M(+15.6%) | $26.58 M(+62.1%) |
| June 2004 | - | $8.81 M(+16.1%) | $16.40 M(+25.3%) |
| Mar 2004 | - | $7.59 M(+38.1%) | $13.08 M(+31.6%) |
| Dec 2003 | $22.66 M(+84.8%) | - | - |
| June 2003 | - | $5.50 M(+23.5%) | $9.95 M(+123.5%) |
| Mar 2003 | - | $4.45 M | $4.45 M |
| Dec 2002 | $12.26 M(+378.2%) | - | - |
| Dec 2001 | $2.56 M(+4830.8%) | - | - |
| Dec 2000 | $52.00 K | - | - |
FAQ
- What is NuVasive annual revenue?
- What is the all time high annual revenue for NuVasive?
- What is NuVasive quarterly revenue?
- What is the all time high quarterly revenue for NuVasive?
- What is NuVasive TTM revenue?
- What is the all time high TTM revenue for NuVasive?
What is NuVasive annual revenue?
The current annual revenue of NUVA is $1.20 B
What is the all time high annual revenue for NuVasive?
NuVasive all-time high annual revenue is $1.20 B
What is NuVasive quarterly revenue?
The current quarterly revenue of NUVA is $317.79 M
What is the all time high quarterly revenue for NuVasive?
NuVasive all-time high quarterly revenue is $317.79 M
What is NuVasive TTM revenue?
The current TTM revenue of NUVA is $1.23 B
What is the all time high TTM revenue for NuVasive?
NuVasive all-time high TTM revenue is $1.23 B